Centauri Therapeutics

Centauri Therapeutics is a UK-based biotechnology company dedicated to the discovery and development of novel molecules for life-threatening diseases. Centauri Therapeutics uses the Alphamer® platform to identify and develop new antimicrobial candidates through first-in-human trials for the treatment of refractory infections.